BSEParmax Pharma LtdMediumNeutral
Announced Wed, 25 Mar · 11:19 IST

Appointment of Ms. Bhakti Aghera as a Company Secretary

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.9%1-day move
₹25.60
prior close
₹27.85
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-5.9+11.1+22.8+21.8+21.0+20.7+19.1+21.1+44.5+193.3
Up moveDown movePending
AI summary

Parmax Pharma Ltd has appointed Ms. Bhakti Aghera (ICSI Membership No. A68683) as the new Company Secretary and Compliance Officer (Key Managerial Personnel) of the company, effective March 25, 2026. The appointment was approved by the Board of Directors on the recommendation of the Nomination and Remuneration Committee. Ms. Aghera is an associate member of the Institute of Company Secretaries of India with six years of experience in corporate legal and secretarial services, and has previously worked with Parmax Pharma Limited. The intimation has been made to BSE under Regulation 30 of the SEBI Listing Regulations.

Likely market impact

This is a routine Key Managerial Personnel appointment that strengthens the company's compliance and secretarial function. It is unlikely to have any material impact on the stock price or shareholder value.